JBIO

JADE BIOSCIENCES INC

JBIO·008064206·US·Common Stock·Healthcare - Biotechnology-Activist

JBIO (JADE BIOSCIENCES INC) is held by 72 institutional investors as of Q1 2026. Largest holders: FMR LLC ($99.6M), RA CAPITAL MANAGEMENT, L.P. ($51.6M), Janus Henderson Group Ltd. ($43.6M). Net institutional sentiment: Mixed.

72
Holders
Avg rating(13 Elite)
$386.6M
Total Value
53% (80)
Fund Consensus
39 buying - 34 selling
JBIOSmart Money Verdict
View all
Held by 72 funds
13 elite
Who's Trading
ActivistJANUS HENDERSON GROUP Ltd.JANUS HENDERSON GROUP Ltd.10.6%Jul 8, 2026
ActivistFAFairmount Funds Management LLC20.0%Jun 9, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC6.3%May 15, 2026
ActivistBlackRock, Inc.BlackRock, Inc.4.7%Apr 27, 2026
ActivistSVSofinnova Venture Partners X, L.P. ("SVP X")0.3%Mar 5, 2026
ActivistBABellevue Group AG6.8%Feb 17, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.9.9%Feb 17, 2026
ActivistDTDeep Track Capital, LP0.0%Feb 13, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.2%Jan 30, 2026
InsiderFTFrohlich TomBuy $44KMay 16, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.1M(+2.8%)$99.6M0.0%+88.47%
31
Unchanged
3.7M$51.6M0.5%+52.73%
0
New
3.1M$43.6M0.0%+50.61%
40
Decreased
2.3M(-19.4%)$32.5M0.0%+95.77%
0
New
1.8M$25.2M0.0%+50.61%
40
Unchanged
1.6M$23.1M0.1%+34.64%
0
Increased
944,776(+7.9%)$13.3M0.0%+38.20%
30
Unchanged
867,284$12.2M0.0%+34.64%
0
Decreased
822,520(-2.3%)$11.6M0.0%+99.13%
0
Increased
655,690(+2.0%)$9.2M0.0%+99.14%
28
Decreased
635,498(-28.4%)$8.9M0.1%+127.97%
0
Decreased
573,205(-60.5%)$8.1M0.1%+127.97%
0
New
402,489$5.7M0.0%+50.61%
37
Decreased
264,315(-52.7%)$3.7M0.0%+34.64%
0
Decreased
241,905(-11.8%)$3.4M0.0%+104.96%
0
New
219,497$3.1M0.0%+50.61%
37
New
211,319$3M0.0%+50.61%
36
Increased
169,051(+151.4%)$2.4M0.0%+43.83%
42
Increased
160,051(+154.8%)$2.2M0.0%+43.91%
42
Increased
153,037(+134.2%)$2.2M0.0%+79.81%
42

Showing 1-20 of 80

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used